You just read:

Eisai Disagrees with German Institute for Quality and Efficiency in Health Care (IQWiG) Report on Innovative Antiepileptic Drug Fycompa® (Perampanel) for the Treatment of Partial Epilepsy

News provided by

Eisai Europe Limited

18 Dec, 2012, 00:01 GMT